Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 331

Nibiru visualises series C1 funding

Real estate developer Dahua’s Huaqiang Capital unit has injected hundreds of millions of yuan into the AR/VR technology provider.

Jan 11, 2021

Jumbotail jumps to series B3 round

Nutresa contributed to a $14.2m round that increased the grocery trading platform developer's overall funding to approximately $54m.

Jan 11, 2021

Showcase Gig finds Glory in new round

The currency processing equipment provider has backed a $9.6m round that pushed mobile payment technology developer Showcase Gig’s total funding to $48m.

Jan 11, 2021

SoftBank fits into $360m Keep series F

The fitness class provider roughly doubled its valuation to $2bn in a round led by SoftBank Vision Fund that included Bertelsmann Asia Investments and Tencent.

Jan 11, 2021

WorkTrans undertakes $140m series D

Tencent participated in the HR management software provider's series D round, which was disclosed together with $50.5m in series C funding.

Jan 11, 2021

MadeiraMadeira kits out $190m round

The furniture-focused e-commerce platform secured the funding in a round co-led by SoftBank as it looks to expand its physical footprint and launch own-brand products.

Jan 11, 2021

Carisma motivates investors for $47m series B

IP Group was among the investors for UPenn-founded cancer immunotherapy developer Carisma Therapeutics, which has now raised nearly $109m altogether.

Jan 11, 2021

Digital Alpha connects to WeLink with $185m

The Cisco-affiliated asset managment firm is now the largest external investor in fixed-wireless broadband service WeLink.

Jan 11, 2021

Mynt rolls out details of $175m investment

Alibaba-affiliated Bow Wave Capital Management has invested $175m in the financial services provider, a joint venture by Globe Telecom, Ant Group and Ayala.

Jan 11, 2021

Visen Pharmaceuticals entices Ascendis to $150m round

The endocrine disease drug developer completed a series B round that included $125m from former parent company Ascendis.

Jan 11, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here